Skip to Main Content

Paper Details

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System.
Saudi Pharm J
2
2023
Author NameAffiliation
Thamir M AlshammariKing Saud University
Thamir M AlshammariAlmaarefa University
Thamir M AlshammariKing Saud University
Thamir M AlshammariAlmaarefa University
  • 1 - 4

Datasets

Release 1.2